Article
Chromatin barcodes as biomarkers for melanoma
7 May 2014
Abstract excerpt
The major barrier to effective cancer therapy is the presence of genetic and phenotypic heterogeneity within cancer cell populations that provides a reservoir of therapeutically resistant cells. As the degree of heterogeneity present within tumours will be proportional to tumour burden, the development of rapid, robust, accurate and sensitive biomarkers for cancer progression that could detect clinically occult...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
